New Zealand (2025, estimated)
6,057.3
USD PPP per capita
-9.8 YoY
Government share
80.6
% of total (2023)
Private share
19.4
% of total (2023)
10-year change
+80.5
% since 2015

Data

Current Health Expenditure per Capita in New Zealand (2025) — source data. OECD.
Year USD PPP per capita YoY Change
2025 6,057.3 -0.2%
2024 6,067.1 +0.1%
2023 6,059 -1.6%
2022 6,158.6 +26.5%
2021 4,869.4 +11.9%
2020 4,352.7 +8.7%
2019 4,003.8 +7.9%
2018 3,712 +0.5%
2017 3,695 +4.2%
2016 3,545.6 +5.7%
2015 3,355.1 +0.6%
2014 3,334.7 +3.0%
2013 3,237.7 +4.6%
2012 3,095.5 +3.2%
2011 3,000.1 +3.8%
2010 2,890.6 +3.1%
2009 2,804.5 +4.3%
2008 2,689.4 +5.9%
2007 2,538.9 +4.1%
2006 2,437.8 +11.1%
2005 2,194.4 n/a

About this Dataset

New Zealand recorded 6,057.3 USD PPP per capita in current health expenditure in 2025, an OECD estimate down -9.8 from 2024's provisional figure of 6,067.1. Spending has risen in most years since 2005, when the series started at 2,194.4 USD PPP, with the steepest jump — +1,289.3 — coming in 2022.

Government and compulsory insurance schemes typically fund most of this spending: in 2023, the last finalized year, they covered about 80.6% of the total (4,880.7 USD PPP per capita), with voluntary insurance and household out-of-pocket payments making up the remaining 19.4% (1,178.3 USD PPP). That split has stayed fairly stable over the past decade, similar to about 81.2% in 2010.

Compared with peer OECD economies, New Zealand's per-capita spending is likely above the typical OECD level — roughly 105.3% of the unweighted OECD-38 average of about 5,755.1 USD PPP in 2023 — though it ran below Australia (7,574.1 USD PPP) and far below the United States (13,932.6 USD PPP) that same year. The chart above shows the full 2005–2025 trend; the table below lists annual values with year-on-year changes.

Data sourced from the OECD System of Health Accounts (SHA) via SDMX REST API, filtered to New Zealand (NZL), total current health expenditure, converted to USD at purchasing power parity. The most recent years are flagged provisional (2024) and estimated (2025) by the OECD and may be revised. The OECD-38 average is an unweighted mean computed across all current OECD member countries with reported data for the comparison year.

Frequently Asked Questions

This indicator tracks total current spending on health care per person in New Zealand, converted to USD at purchasing power parity (PPP) so levels are comparable across countries. It covers spending by government, private insurers, and households, published annually by the OECD under its System of Health Accounts (SHA). The most recent reading is 6,057.3 USD PPP in 2025 (estimated).

The series runs through 2025, though that year is flagged as an OECD estimate and 2024 as a provisional value. The last fully finalized observation is 2023, at 6,059.0 USD PPP per capita. Figures are typically revised as national accounts are finalized, so the 2024 and 2025 values may shift in future OECD updates.

New Zealand's 6,059.0 USD PPP in 2023 (its last finalized year) sat at roughly 105.3% of the unweighted OECD-38 average of about 5,755.1 USD PPP that year — above the typical OECD level. It ran below Australia (7,574.1 USD PPP in 2023) and far below the United States (13,932.6 USD PPP), while sitting fairly close to the United Kingdom (6,664.5 USD PPP).

In 2023, government and compulsory schemes covered an estimated 4,880.7 USD PPP per capita (about 80.6% of the total), while voluntary insurance and household out-of-pocket payments accounted for roughly 1,178.3 USD PPP (about 19.4%). New Zealand's government-funded share has typically stayed high by OECD standards, similar to about 81.2% in 2010.

Per-capita spending has risen in most years since 2005, from 2,194.4 USD PPP that year to 6,057.3 USD PPP in 2025 — an increase of roughly 176% over two decades, and +80.5% just since 2015. The sharpest single-year jump came in 2022, at +1,289.3 USD PPP, with spending easing slightly in 2023 and holding roughly flat through 2024 and 2025.